BioCorRx, Inc. (OTC: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consisting of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers thenon-addictive medicine, Naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx is a one-on-one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term Naltrexone treatment. The company also has a R&D subsidiary, BioCorRx Pharmaceuticals, which is currently developing a new injectable Naltrexone technology (BICX 101) through a partnership with TheraKine Ltd. The company plans to seek FDA approval for BICX 101.